Downturn Concepts and Tools for Biotech Boards
Join Peter Kolchinsky, Tess Cameron, and Dan Lepanto (Senior Managing Director, SVB Securities) for a candid discussion on the array of tools a biotech board can employ in the midst of the current market downturn (June 2022).